Department of Orthopaedic Surgery, Duke University, Durham, North Carolina.
J Arthroplasty. 2024 Aug;39(8):2047-2054.e1. doi: 10.1016/j.arth.2024.02.069. Epub 2024 Feb 28.
This study evaluated blood glucose (BG), creatinine levels, metabolic issues, length of stay (LOS), and early postoperative complications in diabetic primary total knee arthroplasty (TKA) patients. It examined those who continued home oral antidiabetic medications and those who switched to insulin postoperatively. The hypothesis was that continuing home medications would lead to lower BG levels without metabolic abnormalities.
Patients who had diabetes who underwent primary TKA from 2013 to 2022 were evaluated retrospectively. Diabetic patients who were not on home oral antidiabetic medications or who were not managed as an inpatient postoperatively were excluded. Patient demographics and laboratory tests collected preoperatively and postoperatively as well as 90-day emergency department visits and 90-day readmissions, were pulled from electronic records. Patients were grouped based on inpatient diabetes management: continuation of home medications versus new insulin coverage. Acute postoperative BG control, creatinine levels, metabolic abnormalities, LOS, and early postoperative complications were compared between groups. Multivariable regression analyses were performed to measure associations.
A total of 867 primary TKAs were assessed; 703 (81.1%) patients continued their home oral antidiabetic medications. Continuing home antidiabetic medications demonstrated lower median maximum inpatient BG (180.0 mg/dL versus 250.0 mg/dL; P < .001) and median average inpatient BG (136.7 mg/dL versus 173.7 mg/dL; P < .001). Logistic regression analyses supported the presence of an association (odds ratio = 17.88 [8.66, 43.43]; P < .001). Proportions of acute kidney injury (13.5 versus 26.7%; P < .001) were also lower. There was no difference in relative proportions of metabolic acidosis (4.4 versus 3.7%; P = .831), LOS (2.0 versus 2.0 days; P = .259), or early postoperative complications.
Continuing home oral antidiabetic medications after primary TKA was associated with lower BG levels without an associated worsening creatinine or increase in metabolic acidosis.
Retrospective Cohort Study.
本研究评估了糖尿病初次全膝关节置换术(TKA)患者的血糖(BG)、肌酐水平、代谢问题、住院时间(LOS)和术后早期并发症。研究比较了继续服用家庭口服降糖药和术后改用胰岛素的患者。研究假设是继续家庭用药不会导致代谢异常的情况下降低血糖水平。
回顾性评估了 2013 年至 2022 年间接受初次 TKA 的糖尿病患者。排除未服用家庭口服降糖药或术后未接受住院治疗的糖尿病患者。从电子病历中提取术前和术后的患者人口统计学和实验室检查结果以及 90 天急诊就诊和 90 天再入院信息。根据住院期间的糖尿病管理将患者分为两组:继续家庭用药组与新胰岛素覆盖组。比较两组之间的急性术后 BG 控制、肌酐水平、代谢异常、LOS 和术后早期并发症。采用多变量回归分析测量相关性。
共评估了 867 例初次 TKA,703 例(81.1%)患者继续服用家庭口服降糖药。继续家庭口服降糖药的患者,住院期间最大 BG(180.0mg/dL 与 250.0mg/dL;P<.001)和平均 BG(136.7mg/dL 与 173.7mg/dL;P<.001)中位数均较低。Logistic 回归分析支持存在相关性(优势比=17.88[8.66,43.43];P<.001)。急性肾损伤的比例(13.5%与 26.7%;P<.001)也较低。代谢性酸中毒的相对比例(4.4%与 3.7%;P=.831)、LOS(2.0 天与 2.0 天;P=.259)或术后早期并发症无差异。
初次 TKA 后继续服用家庭口服降糖药与较低的 BG 水平相关,而肌酐无相关恶化或代谢性酸中毒增加。
III 级回顾性队列研究。